Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Genes|September 28, 2021
A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML)Alessandra Venanzi, Roberta Rossi, Giovanni Martino, et al.
Cancer|December 22, 2004
Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysisOmbretta Annibali, Maria Teresa Petrucci, Vincenza Martini, et al.
Transfusion|October 29, 2008
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantationMaria Cristina Tirindelli, Gerardo Flammia, Federico Sergi, et al.
Chemotherapy|March 9, 2023
Circulating Endothelial Cell Kinetic in Patients with Multiple Myeloma Who Receive Autologous Hematopoietic Stem Cell TransplantationOmbretta Annibali, Valeria Tomarchio, Chiara Gregorj, et al.
Acta Haematologica|December 1, 2006
Late relapses in acute promyelocytic leukaemiaRoberto Latagliata, Ida Carmosino, Massimo Breccia, et al.
Blood|January 25, 2002
Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problemRoberto Latagliata, Maria Concetta Petti, Susanna Fenu, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2009
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutationGiovanni Galati, Umberto Vespasiani Gentilucci, Ilaria Sansoni, et al.
Acta Haematologica|July 11, 2003
Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myelomaMaria Teresa Petrucci, Giuseppe Avvisati, Giacinto La Verde, et al.
Chemotherapy|February 8, 2024
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell TransplantationOmbretta Annibali, Annamaria Altomare, Valeria Tomarchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patientsDaniele Santini, Bruno Vincenzi, Giordano Dicuonzo, et al.
Pageof 8